CRL Share Price

Open 74.80 Change Price %
High 75.14 1 Day 0.63 0.86
Low 73.60 1 Week 2.28 3.17
Close 74.15 1 Month -1.22 -1.62
Volume 445081 1 Year -1.41 -1.87
52 Week High 89.18
52 Week Low 65.70
CRL Important Levels
Resistance 2 75.58
Resistance 1 74.99
Pivot 74.30
Support 1 73.31
Support 2 72.72
NYSE USA Most Active Stocks
BAC 23.09 0.61%
BAC 23.09 0.61%
BAC 23.09 0.61%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
AMD 10.34 0.00%
More..
NYSE USA Top Gainers Stocks
INVN 10.55 27.57%
POM 26.93 26.79%
POM 26.93 26.79%
EBS 32.37 18.92%
EBS 32.37 18.92%
SWC 17.32 17.98%
SWC 17.32 17.98%
PACD 5.33 17.40%
SDLP 4.48 16.06%
UTI 3.55 14.15%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Charles River Laboratories International, Inc. (NYSE: CRL)

CRL Technical Analysis 3
As on 9th Dec 2016 CRL Share Price closed @ 74.15 and we RECOMMEND Sell for LONG-TERM with Stoploss of 79.32 & Sell for SHORT-TERM with Stoploss of 76.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
CRL Target for December
1st Target up-side 76.58
2nd Target up-side 80.43
3rd Target up-side 84.27
1st Target down-side 65.62
2nd Target down-side 61.77
3rd Target down-side 57.93
CRL Other Details
Segment EQ
Market Capital 1990675072.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.criver.com
CRL Address
CRL
251 Ballardvale Street
Wilmington, MA 01887
United States
Phone: 781-222-6000
CRL Latest News
Interactive Technical Analysis Chart Charles River Laboratories International, Inc. ( CRL NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Charles River Laboratories International, Inc.
CRL Business Profile
Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates through two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment produces and sells research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, and research animal diagnostic services; endotoxin and microbial detection products and services; and avian vaccine products and services. The PCS segment provides preclinical services, including in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. This segment offers services in the areas of bioanalysis, pharmacokinetics, and drug metabolism; toxicology; and pathology services, as well as testing of biologics and devices frequently outsourced by pharmaceutical and biotechnology companies. The company serves pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions worldwide. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.